- ICH GCP
- US Clinical Trials Registry
- Search trials
Example: Heart Attack
Search clinical trials for: Fludarabine
Total 1952 results
-
NCT05888493Not yet recruiting
-
NCT05885464RecruitingLymphoblastic Lymphoma | Lymphoblastic Leukemia | T-Cell Lymphoblastic Leukemia/Lymphoma
-
NCT05886491Not yet recruiting
-
NCT05884333RecruitingNon-Hodgkin's Lymphoma | Myelodysplastic Syndromes (MDS) | Acute Lymphoblastic Leukemia (ALL) | Myeloproliferative Disorder | Acute Myelogenous Leukemia (AML) | Chronic Myelogenous Leukemia (CML)
-
NCT05883449Not yet recruitingPeripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin Lymphoma
-
NCT05881525RecruitingAdvanced Solid Tumors
-
NCT05880043RecruitingAdvanced Solid Tumors | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Non-Hodgkin Lymphoma
-
NCT05877599Not yet recruitingBreast Cancer | Pancreatic Adenocarcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Colorectal Carcinoma | Other Solid Tumors
-
NCT05878184RecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma
-
NCT05876832Not yet recruitingAcute Myeloid Leukemia With FLT3/ITD Mutation
-
NCT05873712Not yet recruitingRecurrent Transformed Non-Hodgkin Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed Non-Hodgkin Lymphoma | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic Leukemia | Refractory Transformed
-
NCT05870995Recruiting
-
NCT05869955Not yet recruitingLupus Erythematosus, Systemic
-
NCT05862324Not yet recruitingMetastatic Solid Tumor
-
NCT05849662Not yet recruitingNeurofibromatosis 1 | JMML | Leukemia, Juvenile Myelomonocytic | JCML | CBL Syndrome
-
NCT05848999RecruitingMesothelin-positive Advanced Malignant Solid Tumors
-
NCT05849207Not yet recruiting
-
NCT05832515Recruiting
-
NCT05831033Not yet recruiting
-
NCT05807932Not yet recruitingMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Secondary Acute Myeloid Leukemia
-
NCT05807659Recruiting
-
NCT05805605RecruitingFollicular Lymphoma | Myelodysplastic Syndromes | Leukemia, Myeloid | Myelofibrosis | Burkitt Lymphoma | Marginal Zone Lymphoma | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia
-
NCT05797233Not yet recruitingLymphoma, B-Cell | Chronic Lymphocytic Leukemia | B-Cell Chronic Lymphocytic Leukemia
-
NCT05798533Recruiting
-
NCT05787574RecruitingImmune System Diseases | Autoimmune Lymphoproliferative | Primary Immune Regulatory Disorder
-
NCT05787535Not yet recruitingCervical Cancer | Head and Neck Squamous Cell Carcinoma | Oropharyngeal Cancer | Anal Carcinoma | Vagina Tumor | Carcinoma of Penis | Carcinoma of Vulva
-
NCT05780879Not yet recruiting
-
NCT05779930Not yet recruitingAcute Lymphoblastic Leukemia, in Relapse | B Cell Leukemia | B-cell Non Hodgkin Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Acute Lymphoblastic Leukemia With Failed Remission
-
NCT05775666Not yet recruiting
-
NCT05776407Not yet recruitingRefractory or Relapsed B Cell Lymphoma
-
NCT05768529RecruitingRelapsed or Refractory Non-Hodgkin's Lymphoma
-
NCT05767359RecruitingMultiple Myeloma | Smoldering Multiple Myeloma
-
NCT05761171Not yet recruitingRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Refractory Acute Leukemia of Ambiguous Lineage | Recurrent Acute Leukemia of Ambiguous Lineage